Clarient, Inc. (NASDAQ:CLRT)

CAPS Rating: 4 out of 5

The Company is an advanced oncology diagnostics technology and services company. It combines innovative technologies and meaningful test results to improve outcomes of patients suffering from cancer.

Recs

0
Player Avatar radsMD (32.27) Submitted: 1/12/2007 8:39:04 PM : Outperform Start Price: $1.68 CLRT Score: +199.02

Speculative but high quality medical diagnostics company with promising product.

Featured Broker Partners


Advertisement